Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
HEPATOLOGY / CLINICAL RESEARCH
Higher lifestyle oxidative balance scores are associated with lower metabolic dysfunction-associated fatty liver disease and fibrosis risk in US adults, while dietary scores have no impact on fibrosis
1
Department of Gastroenterology, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China
These authors had equal contribution to this work
Submission date: 2024-09-16
Final revision date: 2025-02-19
Acceptance date: 2025-03-06
Online publication date: 2025-04-27
KEYWORDS
metabolic dysfunction associated steatotic liver diseaseliver fibrosisoxidative balance scorelifestyle oxidative balance score
TOPICS
ABSTRACT
Introduction:
Metabolic dysfunction related steatotic liver disease (MASLD) is a long-term liver disease. Oxidative stress plays a key role in MASLD. The oxidative balance score (OBS) measures oxidative and reactive stress, but its relationship with MASLD and fibrosis remains unclear.
Material and methods:
The National Health and Nutrition Examination Survey records from 1999 to 2018 were used in this study. We used weighted multivariate logistic regression, subgroup studies, and restricted cubic spline regression to examine the associations between OBS and MASLD and fibrosis. Sensitivity studies were conducted to evaluate the robustness of the results.
Results:
A total of 12,272 people enrolled in the study. There was a strong negative relationship between OBS and MASLD, and all p-values for interactions were less than 0.05. After adjusting for potential confounders, people with higher OBS had a lower risk of MASLD (OR = 0.37, 95% CI (0.27–0.51), p for trend < 0.001). Then, the stratified studies showed that lifestyle OBS was significantly associated with MASLD in both men and women, but dietary OBS was only significantly associated with MASLD in men (OR = 0.95, 95% CI (0.93, 0.98), p < 0.001). Finally, lifestyle OBS showed a strong association with MASLD-related fibrosis (OR = 0.37, 95% CI (0.24, 0.56), p for trend < 0.0001). In the subgroup studies, the findings remained consistent.
Conclusions:
OBS was associated with a lower risk of MASLD, and lifestyle OBS showed strong protective effects against MASLD and fibrosis. Because of this, people who have MASLD and fibrosis should focus on researching and looking into antioxidant treatment that is based on dietary and lifestyle, with particular emphasis on lifestyle factors.
Metabolic dysfunction related steatotic liver disease (MASLD) is a long-term liver disease. Oxidative stress plays a key role in MASLD. The oxidative balance score (OBS) measures oxidative and reactive stress, but its relationship with MASLD and fibrosis remains unclear.
Material and methods:
The National Health and Nutrition Examination Survey records from 1999 to 2018 were used in this study. We used weighted multivariate logistic regression, subgroup studies, and restricted cubic spline regression to examine the associations between OBS and MASLD and fibrosis. Sensitivity studies were conducted to evaluate the robustness of the results.
Results:
A total of 12,272 people enrolled in the study. There was a strong negative relationship between OBS and MASLD, and all p-values for interactions were less than 0.05. After adjusting for potential confounders, people with higher OBS had a lower risk of MASLD (OR = 0.37, 95% CI (0.27–0.51), p for trend < 0.001). Then, the stratified studies showed that lifestyle OBS was significantly associated with MASLD in both men and women, but dietary OBS was only significantly associated with MASLD in men (OR = 0.95, 95% CI (0.93, 0.98), p < 0.001). Finally, lifestyle OBS showed a strong association with MASLD-related fibrosis (OR = 0.37, 95% CI (0.24, 0.56), p for trend < 0.0001). In the subgroup studies, the findings remained consistent.
Conclusions:
OBS was associated with a lower risk of MASLD, and lifestyle OBS showed strong protective effects against MASLD and fibrosis. Because of this, people who have MASLD and fibrosis should focus on researching and looking into antioxidant treatment that is based on dietary and lifestyle, with particular emphasis on lifestyle factors.
REFERENCES (33)
1.
Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-50.
2.
Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 2013; 10: 686-90.
3.
Younossi ZM. Non-alcoholic fatty liver disease – a global public health perspective. J Hepatol 2019; 70: 531-44.
4.
Mitrovic B, Gluvic ZM, Obradovic M, et al. Non-alcoholic fatty liver disease, metabolic syndrome, and type 2 diabetes mellitus: where do we stand today? Arch Med Sci 2022; 19: 884-94.
5.
Rinella ME, Lazarus JV, Ratziu V, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 2023; 79: 1542-56.
6.
Fromenty B, Roden M. Mitochondrial alterations in fatty liver diseases. J Hepatol 2023; 78: 415-29.
7.
Karnia M, Myslinska D, Dzik K, et al. The electrical stimulation of the bed nucleus of the stria terminalis causes oxidative stress in skeletal muscle of rats. Oxid Med Cell Longev 2018; 2018: 4671213.
8.
Yarana C, Carroll D, Chen J, et al. Extracellular vesicles released by cardiomyocytes in a doxorubicin-induced cardiac injury mouse model contain protein biomarkers of early cardiac injury. Clin Cancer Res 2018; 24: 1644-53.
9.
Zhang W, Peng SF, Chen L, Chen HM, Cheng XE, Tang YH. Association between the oxidative balance score and telomere length from the national health and nutrition examination survey 1999-2002. Oxid Med Cell Longev 2022; 2022: 1345071.
10.
Barreiro E, Peinado V, Galdiz J, et al. Cigarette smoke-induced oxidative stress: a role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am J Respir Crit Care Med 2010; 182: 477-88.
11.
Albano E. Alcohol, oxidative stress and free radical damage. Proc Nutr Soc 2006; 65: 278-90.
12.
Hernández-Ruiz Á, García-Villanova B, Guerra-Hernández E, et al. Oxidative balance scores (OBSs) integrating nutrient, food and lifestyle dimensions: development of the NutrientL-OBS and FoodL-OBS. Antioxidants 2022; 11: 300.
13.
Ruhl CE, Everhart JE. Fatty liver indices in the multiethnic United States national health and nutrition examination survey. Aliment Pharmacol Ther 2015; 41: 65-76.
14.
Shah AG, Lydecker A, Murray K, et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009; 7: 1104-12.
15.
Kander MC, Cui Y, Liu Z. Gender difference in oxidative stress: a new look at the mechanisms for cardiovascular diseases. J Cell Mol Med 2017; 21: 1024-32.
16.
Burra P, Bizzaro D, Gonta A, et al. Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Liver Int 2021; 41: 1713-33.
17.
Kumar A, Sharma A, Duseja A, et al. Patients with nonalcoholic fatty liver disease (NAFLD) have higher oxidative stress in comparison to chronic viral hepatitis. J Clin Exp Hepatol 2013; 3: 12-8.
18.
Leghi GE, Domenici FA, Vannucchi H. Influence of oxidative stress and obesity in patients with nonalcoholic steatohepatitis. Arq Gastroenterol 2015; 52: 228-33.
19.
Rives C, Fougerat A, Ellero-Simatos S, et al. Oxidative stress in NAFLD: role of nutrients and food contaminants. Biomol Ther 2020; 10: 21702.
20.
Cheraghpour M, Imani H, Ommi S, et al. Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled, double-blind clinical trial. Phytother Res 2019; 33: 2118-25.
21.
Farzanegi P, Dana A, Ebrahimpoor Z, Asadi M, Azarbayjani MA. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): roles of oxidative stress and inflammation. Eur J Sport Sci 2019; 19: 994-1003.
22.
Romero-Gómez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol 2017; 67: 829-46.
23.
Noruzi Z, Jayedi A, Farazi M, et al. Association of oxidative balance score with the metabolic syndrome in a sample of Iranian adults. Oxid Med Cell Longev 2021; 2021: 5593919.
24.
Lee JH, Son DH, Kwon YJ. Association between oxidative balance score and new-onset hypertension in adults: a community-based prospective cohort study. Front Nutr 2022; 9: 1066159.
25.
Golmohammadi M, Ayremlou P, Zarrin R. Higher oxidative balance score is associated with better glycemic control among Iranian adults with type-2 diabetes. Int J Vitam Nutr Res 2021; 91: 31-9.
26.
Hernandez-Ruiz A, Garcia-Villanova B, Guerra-Hernandez E, Amiano P, RuizCanela M, Molina-Montes E. A review of A priori defined oxidative balance scores relative to their components and impact on health outcomes. Nutrients 2019; 11: 774.
27.
Yi Y, Wang C, Ding Y, He J, Lv Y, Chang Y. Diet was less significant than physical activity in the prognosis of people with sarcopenia and metabolic dysfunction-associated fatty liver diseases: analysis of the National Health and nutrition examination survey III. Front Endocrinol 2023; 14: 1101892.
28.
Li L, Yi Y, Shu X, Li J, Kang H, Chang Y. The correlation between serum copper and non-alcoholic fatty liver disease in American adults: an analysis based on NHANES 2011 to 2016. Biol Trace Elem Res 2024; 202: 4398-409.
29.
Liu X, Shen H, Chen M, Shao J. Clinical relevance of vitamins and carotenoids with liver steatosis and fibrosis detected by transient elastography in adults. Front Nutr 2021; 8: 760985.
30.
Kim D, Konyn P, Cholankeril G, Ahmed A. Physical activity is associated with nonalcoholic fatty liver disease and significant fibrosis measured by FibroScan. Clin Gastroenterol Hepatol 2022; 20: e1438.
31.
Chen G, Banini B, Do A, Lim JK. The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: a systematic review. Clin Mol Hepatol 2023; 29: S319-32.
32.
Houttu V, Bouts J, Vali Y, et al. Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis. Front Endocrinol 2022; 13: 1032164.
33.
Wang M, Ma LJ, Yang Y, Xiao Z, Wan JB. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: a critical review. Crit Rev Food Sci Nutr 2019; 59: S116-29.
Share
RELATED ARTICLE
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
